Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

PBH Prestige Consumer Healthcare Inc

84,36

0,73 (0,87%)

Dopo l'orario di negoziazione

Ultimo aggiornamento: 23:55:53

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/S/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Ronald Lombardi

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Prestige Consumer Health... (NYSE:PBH)
Storico
Da Feb 2025 a Mar 2025

Clicca qui per i Grafici di Prestige Consumer Health...

Grafico Azioni Prestige Consumer Health... (NYSE:PBH)
Storico
Da Mar 2024 a Mar 2025

Clicca qui per i Grafici di Prestige Consumer Health...

Notizie Prestige Consumer Healthcare Inc - PBH

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 12 Marzo 2025 (1 settimana fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunedì 10 Marzo 2025 (1 settimana fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 5 Marzo 2025 (2 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 13 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Martedì 11 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Venerdì 7 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Giovedì 6 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 6 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
Giovedì 6 Febbraio 2025 (1 mese fa) • GlobeNewswire Inc.

Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
Giovedì 9 Gennaio 2025 (2 mesi fa) • GlobeNewswire Inc.

Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
Lunedì 6 Gennaio 2025 (2 mesi fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 10 Dicembre 2024 (3 mesi fa) • Edgar (US Regulatory)

Più Prestige Consumer Healthcare Inc Articoli Notizie

Injective Token

DIIN25V25 - 07/2025

TIME FOR FUN ON

BANCO DO BRASIL ON

Nine Entertainment

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni